Hologic, Inc. (NASDAQ:HOLX – Free Report) – Investment analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for Hologic in a research report issued on Thursday, February 22nd. Zacks Research analyst R. Anand now anticipates that the medical equipment provider will post earnings per share of $1.10 for the quarter, down […]